 
| Course: |
Infectious Diseases 1606
|
| Target Audience: |
| This activity is intended for the infectious disease specialist. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
| AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
| Faculty |
Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center
Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center
Executive Editor
Gary Evans
AHC Media
Associate Editors
Dean L. Winslow, MD, FACP, FIDSA
Chairman, Department of Medicine
Santa Clara Valley, Medical Center
Clinical Professor
Stanford University School of Medicine
Brian Blackburn, MD
Clinical Assistant Professor of Medicine
Division of Infectious Diseases and Geographic Medicine
Stanford University School of Medicine
Author
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
|
| Subjects: |
- Azithromycin The Heart of the Matter
- Fatal Outcomes Following Family Transmission of M. pneumoniae
- Linezolid for Nosocomial MRSA Pneumonia: A Better Option?
- Should Cefazolin be Preferred Treatment for Methicillin-susceptible S. aureus Bacteremia Instead of Nafcillin?
- The Most Common Cause of Encephalitis?
- HPV-related Oral Cancers Increase by 225% in U.S. from 1988 to 2004
- Updates
|
| Objectives: |
- discuss the diagnosis and treatment of infectious diseases
- explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
- discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
- discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies
|
| Financial Disclosure: |
Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck.
Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck.
Peer Reviewer Timothy Jenkins, MD, Executive Editor Gary Evans, Associate Editor Brian Blackburn, MD, Author Richard R. Watkins, MD, MS, FACP report no financial relationship relavent to this field of study.
Associate Editor Dean L. Winslow, MD, FACP, FIDSA is a consultant for Siemens Diagnostic.
Copyright 2012 AHC Media. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
